Comparison Overview
Noble, An Aptar Pharma Company

Noble, An Aptar Pharma Company
121 South Orange Avenue, Orlando, FL 32801, US
Last Update: 27/10/2025
Noble is focused on fostering healthy patient outcomes for those who self-administer drug therapies, through the development of robust training devices and onboarding solutions for the world’s top pharma brands and biotech companies. Noble manufactures and commercialize...

Merck Group
Frankfurter Str. 250, Darmstadt, DE, 64293
Last Update: 06/09/2026
This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, U...
Compliance Ranges Comparison

Noble, An Aptar Pharma Company







Merck Group






Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Noble, An Aptar Pharma Company in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Merck Group in 2026.
Incident History - Noble, An Aptar Pharma Company (X = Date, Y = Severity)
Noble, An Aptar Pharma Company cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Merck Group (X = Date, Y = Severity)
Merck Group cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Noble, An Aptar Pharma Company

Merck Group
FAQ
Latest Global CVEs
Netskope was notified about a potential gap in Netskope Endpoint DLP (EPDLP) running on Windows systems. Successful exploitation of the gap could potentially allow a privileged user to send a crafted message to the EPDLP process port to trigger an integer overflow, leading to memory corruption. Successful exploitation would require the EPDLP module to be enabled in the client configuration, and that Memory Integrity is disabled. A successful exploit could potentially result in a denial-of-service, arbitrary code execution, or privilege escalation on the local machine.
Netskope was notified of an out-of-bounds heap read affecting the Endpoint DLP (EPDLP) service of the Netskope Client. A local standard user could potentially send a specially crafted message that is not properly validated with a bounds check, likely crashing the kernel driver handler. Successful exploitation could potentially crash the EPDLP service, temporarily interrupting DLP enforcement. A successful exploit could potentially also reveal per-boot memory layout information to unauthorized users.
IBM Db2 11.5.0 through 11.5.9, and 12.1.0 through 12.1.5 is vulnerable to a denial of service where a specific functionality on a Db2 server can be disabled by a privileged user under certain conditions.
IBM Db2 11.5.0 through 11.5.9, and 12.1.0 through 12.1.5 could allow an attacker with the ability to control or impersonate a DRDA server endpoint to execute arbitrary commands on Db2 clients due to a stack-based buffer overflow that improperly copies user-controlled data into a fixed-size stack buffer without bounds checking.
IBM Db2 11.5.0 through 11.5.9, and 12.1.0 through 12.1.5 could allow an authenticated user to send a specially crafted request to write arbitrary files on the system.